SPY312.97+2.45 0.79%
DIA259.43+2.12 0.82%
IXIC10,247.36+92.73 0.91%

Needham Maintains Buy on Seattle Genetics, Raises Price Target to $188

Needham analyst Chad Messer maintains Seattle Genetics (NASDAQ:SGEN) with a Buy and raises the price target from $163 to $188.

Benzinga · -
Needham analyst Chad Messer maintains Seattle Genetics (NASDAQ: SGEN) with a Buy and raises the price target from $163 to $188.